Outcomes with distal transradial access in patients with advanced chronic kidney disease.

IF 1.6 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Invasive Cardiology Pub Date : 2024-08-14 DOI:10.25270/jic/24.00200

Ramya C Mosarla, Hamza Ahmed, Shaline D Rao, Bernard S Kadosh, Jennifer A Cruz, Randal I Goldberg, Tajinderpal Saraon, Bruce E Gelb, Aprajita Mattoo, Sunil V Rao, Sripal Bangalore

{"title":"Outcomes with distal transradial access in patients with advanced chronic kidney disease.","authors":"Ramya C Mosarla, Hamza Ahmed, Shaline D Rao, Bernard S Kadosh, Jennifer A Cruz, Randal I Goldberg, Tajinderpal Saraon, Bruce E Gelb, Aprajita Mattoo, Sunil V Rao, Sripal Bangalore","doi":"10.25270/jic/24.00200","DOIUrl":null,"url":null,"abstract":"<p><p>Radial artery occlusion (RAO), a complication of transradial access, has an incidence of 4.0% to 9.1% in patients with advanced chronic kidney disease (CKD) and may preclude its use creation of arteriovenous fistula. Distal transradial access (dTRA) has lower rates of RAO compared with TRA, but prior studies excluded patients with advanced CKD. This was a single center study of patients with advanced CKD who underwent coronary procedures with dTRA from January 1, 2019 to May 12, 2022 who were retrospectively evaluated for radial artery patency in follow-up with reverse Barbeau testing or repeat access of the artery. Of 71 patients, 66% were on hemodialysis and the remainder had CKD 3 to 5. Access was ultrasound-guided, and all received adequate spasmolytic therapy and patent hemostasis. Proximal radial arteries were patent in 100% of the patients at follow-up. Our data suggest that dTRA is safe for patients with advanced CKD and preserves radial artery patency.</p>","PeriodicalId":49261,"journal":{"name":"Journal of Invasive Cardiology","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Invasive Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25270/jic/24.00200","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Radial artery occlusion (RAO), a complication of transradial access, has an incidence of 4.0% to 9.1% in patients with advanced chronic kidney disease (CKD) and may preclude its use creation of arteriovenous fistula. Distal transradial access (dTRA) has lower rates of RAO compared with TRA, but prior studies excluded patients with advanced CKD. This was a single center study of patients with advanced CKD who underwent coronary procedures with dTRA from January 1, 2019 to May 12, 2022 who were retrospectively evaluated for radial artery patency in follow-up with reverse Barbeau testing or repeat access of the artery. Of 71 patients, 66% were on hemodialysis and the remainder had CKD 3 to 5. Access was ultrasound-guided, and all received adequate spasmolytic therapy and patent hemostasis. Proximal radial arteries were patent in 100% of the patients at follow-up. Our data suggest that dTRA is safe for patients with advanced CKD and preserves radial artery patency.

查看原文本刊更多论文

晚期慢性肾病患者经桡动脉远端入路的疗效。

桡动脉闭塞（RAO）是经桡动脉入路的一种并发症，在晚期慢性肾脏病（CKD）患者中的发病率为 4.0% 至 9.1%，可能导致无法使用经桡动脉入路建立动静脉瘘。经桡动脉远端入路（dTRA）与 TRA 相比，RAO 发生率较低，但之前的研究排除了晚期 CKD 患者。这是一项针对晚期 CKD 患者的单中心研究，这些患者在 2019 年 1 月 1 日至 2022 年 5 月 12 日期间接受了 dTRA 冠状动脉手术，并在随访中通过反向 Barbeau 测试或动脉重复入路对桡动脉通畅性进行了回顾性评估。在 71 名患者中，66% 正在进行血液透析，其余为 CKD 3 至 5。所有患者都在超声引导下接受了充分的解痉治疗和止血。随访时，100% 的患者桡动脉近端通畅。我们的数据表明，dTRA 对晚期 CKD 患者是安全的，并能保留桡动脉的通畅性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Invasive Cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

2.90

自引率

6.70%

发文量

214

审稿时长

3-8 weeks

期刊介绍： The Journal of Invasive Cardiology will consider for publication suitable articles on topics pertaining to the invasive treatment of patients with cardiovascular disease.